Zhang et al., 1994 - Google Patents
Femtosecond studies of hematoporphyrin derivative in solution: effect of pH and solvent on the excited state dynamicsZhang et al., 1994
- Document ID
- 18060300444810639332
- Author
- Zhang J
- O'Neil R
- Evans J
- Publication year
- Publication venue
- Photochemistry and photobiology
External Links
Snippet
We report direct femtosecond measurements of the excited state dynamics of hematoporphyrin derivative (HpD) in solution. The dynamics are found to be very sensitive to the solvent and pH of aqueous solutions. The decay of the excited singlet states is much …
- 230000005281 excited state 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0009—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation
- A61K41/0019—Inactivation or decontamination of a medicinal preparation prior to administration to the animal or human, e.g. : inactivation of viruses or bacteria for vaccines, sterilisation by electromagnetic radiation by UV, IR, Rx or gamma rays
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bonnett et al. | Photophysical properties of meso‐tetraphenylporphyrin and some meso‐tetra (hydroxyphenyl) porphyrins | |
Patterson et al. | Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy | |
Hadjur et al. | Spectroscopic studies of photobleaching and photoproduct formation of meta (tetrahydroxyphenyl) chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC | |
Detty et al. | Chalcogenapyrylium dyes as potential photochemotherapeutic agents. Solution studies of heavy atom effects on triplet yields, quantum efficiencies of singlet oxygen generation, rates of reaction with singlet oxygen, and emission quantum yields | |
Oliveira et al. | Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency | |
Staicu et al. | Studies about phthalocyanine photosensitizers to be used in photodynamic therapy | |
EP0361936B1 (en) | Lasing compositions and methods for using the same | |
Kelbauskas et al. | Internalization of Aggregated Photosensitizers by Tumor Cells: Subcellular Time‐resolved Fluorescence Spectroscopy on Derivatives of Pyropheophorbide‐a Ethers and Chlorin e6 under Femtosecond One‐and Two‐photon Excitation¶ | |
Redmond et al. | THERMAL‐LENSING AND PHOSPHORESCENCE STUDIES OF THE QUANTUM YIELD AND LIFETIME OF SINGLET MOLECULAR OXYGEN (1 Δg) SENSITIZED BY HEMATOPORPHYRIN AND RELATED PORPHYRINS IN DEUTERATED AND NON‐DEUTERATED ETHANOLS | |
Moan et al. | Photoproducts formed from photofrin II in cells | |
Teuchner et al. | Spectroscopic properties of potential sensitizers for new photodynamic therapy start mechanisms via two‐step excited electronic states | |
Pogue et al. | Photophysical properties of tin ethyl etiopurpurin I (SnET2) and tin octaethylbenzochlorin (SnOEBC) in solution and bound to albumin | |
Kunz et al. | Intracellular Photobleaching of 5, 10, 15, 20‐Tetrakis (m‐hydroxyphenyl) chlorin (Foscan®) Exhibits a Complex Dependence on Oxygen Level and Fluence Rate¶ | |
Juvekar et al. | Two-photon excitation photosensitizers for photodynamic therapy: From small-molecules to nano-complex systems | |
Moore | 2 CHAPTER Photophysical and Photochemical Aspects of Drug Stability | |
Katona et al. | Triplet state spectroscopic studies on some 5, 10, 15, 20-tetrakis (methoxyphenyl) porphyrins | |
Zhang et al. | Femtosecond studies of hematoporphyrin derivative in solution: effect of pH and solvent on the excited state dynamics | |
Yova et al. | Photochemical effects and hypericin photosensitized processes in collagen | |
Stiel et al. | Photophysical properties of the photosensitizer pheophorbide a studied at high photon flux densities | |
Pelegrino et al. | Photophysical Properties of Crowned Porphyrins¶ | |
Howe et al. | Time‐resolved studies of the excited‐state dynamics of meso‐tetra (hydroxylphenyl) chlorin in solution | |
Maestrin et al. | Synthesis, spectroscopy and photosensitizing properties of hydroxynitrophenylporphyrins | |
Li et al. | Singlet oxygen quantum yields of porphyrin-based photosensitizers for photodynamic therapy | |
Gerhardt et al. | Photophysical behaviour of an opp-dibenzoporphyrin (2, 12-diethyl-3, 13-dimethyldibenzo [g, q] porphyrin) in micelles and organic solvents | |
Gadonas et al. | Singlet-singlet and triplet-triplet absorption of hematoporphyrin diacetate |